Table 1 Clinical and biochemical characteristics of the study participants
From: Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon
|  | Mean ± SD | p | ||
|---|---|---|---|---|
Patients on ART (n = 91) | ART-naïve patients (n = 30) | Overall (n = 121) | ||
Age (years) | 40.3 ± 9.9 | 38.5 ± 11.8 | 39.8 ± 10.4 | 0.327 |
Sex (Male/Female) | 22/69 | 6/24 | 28/93 | 0.638 |
CDC Clinical Classification (A/C) | 90/1 | 30/0 | 120/1 | 0.752 |
CD4 count (cells/mm 3 ) | 410.4 ± 231.9 | 261.8 ± 173.0 | 373.2 ± 226.9 | 0.192 |
AST (IU/L) | 27.8 ± 15.9 | 25.6 ± 10.1 | 27.3 ± 14.6 | 0.171 |
ALT (IU/L) | 25.6 ± 20.8 | 23.1 ± 8.3 | 24.9 ± 18.4 | 0.104 |
FPG (g/L) | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.564 |
LDH (IU/L) | 441.1 ± 138.1 | 485.1 ± 168.6 | 452.0 ± 146.8 | 0.253 |
Lactataemia (mmol/L) | 2.3 ± 1.3 | 1.7 ± 0.7 | 2.2 ± 1.2 | 0.002* |
Hyperlactatemic patients (%) | 18.7 | 6.7 | 15.7 | 0.095 |